Kanker Payudara

A Beacon of Hope: Gene Therapy Breakthrough Targets Rare Inherited Blindness

Asro September 22, 2026

In a landmark development for ocular medicine, Beacon Therapeutics has announced that its investigational gene therapy, laru-zova,...

Breakthrough in Precision Oncology: Zidesamtinib Shows Unprecedented Efficacy in ROS1-Positive NSCLC breakthrough-in-precision-oncology-zidesamtinib-shows-unprecedented-efficacy-in-ros1-positive-nsclc

Breakthrough in Precision Oncology: Zidesamtinib Shows Unprecedented Efficacy in ROS1-Positive NSCLC

Basiran September 22, 2026

Main Facts: A New Frontier in Targeted Lung Cancer Therapy At the 2026 World Conference on Lung...

Beyond the Prescription: Redefining Oncology Care in the Era of Personalized Medicine beyond-the-prescription-redefining-oncology-care-in-the-era-of-personalized-medicine

Beyond the Prescription: Redefining Oncology Care in the Era of Personalized Medicine

Laily UPN September 21, 2026

The landscape of oncology is undergoing a seismic shift. For decades, the cancer care paradigm was anchored...

The Great Medicaid Retrenchment: Managed Care Faces a New Era of Volatility and Market Exits the-great-medicaid-retrenchment-managed-care-faces-a-new-era-of-volatility-and-market-exits

The Great Medicaid Retrenchment: Managed Care Faces a New Era of Volatility and Market Exits

Ali Ikhwan September 21, 2026

The landscape of American public health coverage is currently undergoing a structural shift. With over three-quarters of...

The Golden Legume: How the Peanut Sustains the Wiregrass Economy the-golden-legume-how-the-peanut-sustains-the-wiregrass-economy

The Golden Legume: How the Peanut Sustains the Wiregrass Economy

Lina Hope September 21, 2026

For over a century, the landscape of the American South—specifically the Wiregrass region—has been defined by the...

A New Dawn in Breast Cancer Care: Penn Scientists Unveil Strategy to Eradicate Dormant Cells and Prevent Recurrence a-new-dawn-in-breast-cancer-care-penn-scientists-unveil-strategy-to-eradicate-dormant-cells-and-prevent-recurrence

A New Dawn in Breast Cancer Care: Penn Scientists Unveil Strategy to Eradicate Dormant Cells and Prevent Recurrence

Siti Muinah September 21, 2026

PHILADELPHIA, PA – In a groundbreaking development poised to redefine breast cancer survivorship, scientists from the Abramson...

AI Breakthrough: Enhancing Patient Safety in High-Volume Liposuction Through Predictive Modeling ai-breakthrough-enhancing-patient-safety-in-high-volume-liposuction-through-predictive-modeling

AI Breakthrough: Enhancing Patient Safety in High-Volume Liposuction Through Predictive Modeling

Iffa Jayyana September 21, 2026

In a significant leap forward for cosmetic surgery, a newly developed artificial intelligence (AI) model is setting...

Healthier Beginnings, Hopeful Futures: A Global Mobilization for Maternal and Newborn Survival healthier-beginnings-hopeful-futures-a-global-mobilization-for-maternal-and-newborn-survival

Healthier Beginnings, Hopeful Futures: A Global Mobilization for Maternal and Newborn Survival

Iffa Jayyana September 21, 2026

Geneva, Switzerland — As the World Health Organization (WHO) celebrated its 77th anniversary on April 7, 2025,...

The New Frontier of Global Health: How Strategic Philanthropy is Reshaping WHO’s Vision for Equity the-new-frontier-of-global-health-how-strategic-philanthropy-is-reshaping-whos-vision-for-equity

The New Frontier of Global Health: How Strategic Philanthropy is Reshaping WHO’s Vision for Equity

Nila Kartika Wati September 21, 2026

Introduction: A Paradigm Shift in Global Health Financing The landscape of global health is undergoing a profound...

Accro Bioscience Initiates Phase IIb Trial for AC-101 in Ulcerative Colitis, Targeting Novel Inflammatory Pathway accro-bioscience-initiates-phase-iib-trial-for-ac-101-in-ulcerative-colitis-targeting-novel-inflammatory-pathway

Accro Bioscience Initiates Phase IIb Trial for AC-101 in Ulcerative Colitis, Targeting Novel Inflammatory Pathway

Nila Kartika Wati September 21, 2026

A significant step forward in the quest for more effective treatments for ulcerative colitis (UC) has been...

A Beacon of Hope: Gene Therapy Breakthrough Targets Rare Inherited Blindness

Breakthrough in Precision Oncology: Zidesamtinib Shows Unprecedented Efficacy in ROS1-Positive NSCLC

Beyond the Prescription: Redefining Oncology Care in the Era of Personalized Medicine

The Great Medicaid Retrenchment: Managed Care Faces a New Era of Volatility and Market Exits

The Golden Legume: How the Peanut Sustains the Wiregrass Economy

A New Dawn in Breast Cancer Care: Penn Scientists Unveil Strategy to Eradicate Dormant Cells and Prevent Recurrence

AI Breakthrough: Enhancing Patient Safety in High-Volume Liposuction Through Predictive Modeling

Healthier Beginnings, Hopeful Futures: A Global Mobilization for Maternal and Newborn Survival

The New Frontier of Global Health: How Strategic Philanthropy is Reshaping WHO’s Vision for Equity

Accro Bioscience Initiates Phase IIb Trial for AC-101 in Ulcerative Colitis, Targeting Novel Inflammatory Pathway

You may have missed

Viking Therapeutics Gains Momentum: Breakthrough Results Bolster Case for Flexible Obesity Treatment Dosing

Looming Healthcare Crisis: Impact of the 2025 Reconciliation Law on Immigrant Coverage

Bridging the Gap: METAvivor Joins Coalition to Dismantle Financial Barriers in Clinical Research

The Compounded GLP-1 Gold Rush: A Regulatory and Public Health Crisis